CA2611266A1 - Utilisation de conjugues avec des lieurs clivables par photodissociation ou par fragmentation a des fins d'analyse par spectrometrie de masse des parties du tissu - Google Patents

Utilisation de conjugues avec des lieurs clivables par photodissociation ou par fragmentation a des fins d'analyse par spectrometrie de masse des parties du tissu Download PDF

Info

Publication number: CA2611266A1
Authority: CA; Canada
Prior art keywords: molecule; peptide; maldi; tag; target
Prior art date: 2005-06-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA002611266A

Other languages

English (en)

Other versions

CA2611266C (fr

Inventor

Remi Lemaire

Isabelle Fournier

Michel Salzet

Michel Deschamps

Edmond Jean-Claude Tabet

Gottfried Proess

Ivo Rudloff

Marc Lemaitre

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kaneka Eurogentec SA

Centre National de la Recherche Scientifique CNRS

Universite Lille 1 Sciences et Technologies

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-07

Filing date

2006-06-07

Publication date

2007-01-04

2006-06-07 Application filed by Individual filed Critical Individual

2007-01-04 Publication of CA2611266A1 publication Critical patent/CA2611266A1/fr

2015-11-24 Application granted granted Critical

2015-11-24 Publication of CA2611266C publication Critical patent/CA2611266C/fr

Status Expired - Fee Related legal-status Critical Current

2026-06-07 Anticipated expiration legal-status Critical

Links

238000004949 mass spectrometry Methods 0.000 title claims abstract description 60
238000013467 fragmentation Methods 0.000 title claims abstract description 40
238000006062 fragmentation reaction Methods 0.000 title claims abstract description 40
238000006303 photolysis reaction Methods 0.000 title abstract description 14
238000000034 method Methods 0.000 claims abstract description 67
230000027455 binding Effects 0.000 claims abstract description 41
238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 claims abstract description 33
238000000688 desorption electrospray ionisation Methods 0.000 claims abstract description 20
238000003795 desorption Methods 0.000 claims abstract description 19
108090000765 processed proteins & peptides Proteins 0.000 claims description 109
108020004999 messenger RNA Proteins 0.000 claims description 67
102000004169 proteins and genes Human genes 0.000 claims description 55
239000000523 sample Substances 0.000 claims description 54
108090000623 proteins and genes Proteins 0.000 claims description 53
102000004196 processed proteins & peptides Human genes 0.000 claims description 43
150000007523 nucleic acids Chemical class 0.000 claims description 25
108020004707 nucleic acids Proteins 0.000 claims description 24
102000039446 nucleic acids Human genes 0.000 claims description 24
108020004711 Nucleic Acid Probes Proteins 0.000 claims description 22
239000002853 nucleic acid probe Substances 0.000 claims description 22
239000000427 antigen Substances 0.000 claims description 21
108091007433 antigens Proteins 0.000 claims description 21
102000036639 antigens Human genes 0.000 claims description 21
-1 antibodies Substances 0.000 claims description 18
230000000295 complement effect Effects 0.000 claims description 13
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 10
108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 10
108091034117 Oligonucleotide Proteins 0.000 claims description 10
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 10
239000010931 gold Substances 0.000 claims description 10
229910052737 gold Inorganic materials 0.000 claims description 10
108020003175 receptors Proteins 0.000 claims description 9
102000005962 receptors Human genes 0.000 claims description 9
150000002894 organic compounds Chemical class 0.000 claims description 8
239000003446 ligand Substances 0.000 claims description 7
235000000346 sugar Nutrition 0.000 claims description 6
150000008163 sugars Chemical class 0.000 claims description 6
108091023037 Aptamer Proteins 0.000 claims description 5
102000004190 Enzymes Human genes 0.000 claims description 5
108090000790 Enzymes Proteins 0.000 claims description 5
229960002685 biotin Drugs 0.000 claims description 5
235000020958 biotin Nutrition 0.000 claims description 5
239000011616 biotin Substances 0.000 claims description 5
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 4
229920000642 polymer Polymers 0.000 claims description 3
125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 2
150000002632 lipids Chemical class 0.000 claims description 2
239000000562 conjugate Substances 0.000 description 63
238000004458 analytical method Methods 0.000 description 52
AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 31
102000015636 Oligopeptides Human genes 0.000 description 31
108010038807 Oligopeptides Proteins 0.000 description 31
238000001514 detection method Methods 0.000 description 29
238000005516 engineering process Methods 0.000 description 27
101150040913 DUT gene Proteins 0.000 description 25
239000000863 peptide conjugate Substances 0.000 description 22
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
239000012634 fragment Substances 0.000 description 21
102100038931 Proenkephalin-A Human genes 0.000 description 20
230000015572 biosynthetic process Effects 0.000 description 20
108010041071 proenkephalin Proteins 0.000 description 20
229940127131 antibody-peptide-conjugate Drugs 0.000 description 19
238000003786 synthesis reaction Methods 0.000 description 19
238000009396 hybridization Methods 0.000 description 18
239000011159 matrix material Substances 0.000 description 16
239000000243 solution Substances 0.000 description 16
239000011347 resin Substances 0.000 description 15
229920005989 resin Polymers 0.000 description 15
238000006243 chemical reaction Methods 0.000 description 14
PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 13
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 12
BRARRAHGNDUELT-UHFFFAOYSA-N 3-hydroxypicolinic acid Chemical compound OC(=O)C1=NC=CC=C1O BRARRAHGNDUELT-UHFFFAOYSA-N 0.000 description 11
241000700159 Rattus Species 0.000 description 11
AFVLVVWMAFSXCK-VMPITWQZSA-N alpha-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(\C#N)=C\C1=CC=C(O)C=C1 AFVLVVWMAFSXCK-VMPITWQZSA-N 0.000 description 11
PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 11
238000007901 in situ hybridization Methods 0.000 description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
230000003321 amplification Effects 0.000 description 9
150000001875 compounds Chemical class 0.000 description 9
238000003199 nucleic acid amplification method Methods 0.000 description 9
238000012408 PCR amplification Methods 0.000 description 8
238000003776 cleavage reaction Methods 0.000 description 8
150000002500 ions Chemical class 0.000 description 8
230000007017 scission Effects 0.000 description 8
238000001228 spectrum Methods 0.000 description 8
241000283973 Oryctolagus cuniculus Species 0.000 description 7
210000004556 brain Anatomy 0.000 description 7
230000004807 localization Effects 0.000 description 7
238000013507 mapping Methods 0.000 description 7
239000000463 material Substances 0.000 description 7
108090000018 Carboxypeptidase D Proteins 0.000 description 6
102100032407 Carboxypeptidase D Human genes 0.000 description 6
229910052786 argon Inorganic materials 0.000 description 6
210000005013 brain tissue Anatomy 0.000 description 6
125000001246 bromo group Chemical group Br* 0.000 description 6
238000002372 labelling Methods 0.000 description 6
239000000203 mixture Substances 0.000 description 6
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 5
108010004469 allophycocyanin Proteins 0.000 description 5
230000008901 benefit Effects 0.000 description 5
235000011178 triphosphate Nutrition 0.000 description 5
239000001226 triphosphate Substances 0.000 description 5
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 5
WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 4
DLZKEQQWXODGGZ-KCJUWKMLSA-N 2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DLZKEQQWXODGGZ-KCJUWKMLSA-N 0.000 description 4
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
241000283707 Capra Species 0.000 description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
239000003153 chemical reaction reagent Substances 0.000 description 4
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 4
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 4
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 4
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 4
238000000605 extraction Methods 0.000 description 4
238000003384 imaging method Methods 0.000 description 4
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
239000000126 substance Substances 0.000 description 4
125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 3
HORQAOAYAYGIBM-UHFFFAOYSA-N 2,4-dinitrophenylhydrazine Chemical compound NNC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O HORQAOAYAYGIBM-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
102000002260 Alkaline Phosphatase Human genes 0.000 description 3
108020004774 Alkaline Phosphatase Proteins 0.000 description 3
241000282414 Homo sapiens Species 0.000 description 3
230000001133 acceleration Effects 0.000 description 3
230000000890 antigenic effect Effects 0.000 description 3
239000000872 buffer Substances 0.000 description 3
238000001819 mass spectrum Methods 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000000746 purification Methods 0.000 description 3
238000004445 quantitative analysis Methods 0.000 description 3
238000011160 research Methods 0.000 description 3
238000003757 reverse transcription PCR Methods 0.000 description 3
238000004007 reversed phase HPLC Methods 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000002904 solvent Substances 0.000 description 3
JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 3
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 3
YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 3
239000003643 water by type Substances 0.000 description 3
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
XLEYFDVVXLMULC-UHFFFAOYSA-N 2',4',6'-trihydroxyacetophenone Chemical compound CC(=O)C1=C(O)C=C(O)C=C1O XLEYFDVVXLMULC-UHFFFAOYSA-N 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
108020004414 DNA Proteins 0.000 description 2
108700039887 Essential Genes Proteins 0.000 description 2
102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 2
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 2
108010052285 Membrane Proteins Proteins 0.000 description 2
102000018697 Membrane Proteins Human genes 0.000 description 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
108091005461 Nucleic proteins Proteins 0.000 description 2
101710176384 Peptide 1 Proteins 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
239000004809 Teflon Substances 0.000 description 2
229920006362 Teflon® Polymers 0.000 description 2
239000000654 additive Substances 0.000 description 2
230000000996 additive effect Effects 0.000 description 2
238000013019 agitation Methods 0.000 description 2
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
239000012491 analyte Substances 0.000 description 2
125000004429 atom Chemical group 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
102000003675 cytokine receptors Human genes 0.000 description 2
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
101150047356 dec-1 gene Proteins 0.000 description 2
230000001627 detrimental effect Effects 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
239000011521 glass Substances 0.000 description 2
238000003365 immunocytochemistry Methods 0.000 description 2
238000000752 ionisation method Methods 0.000 description 2
239000002184 metal Substances 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000013642 negative control Substances 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
238000007899 nucleic acid hybridization Methods 0.000 description 2
239000012071 phase Substances 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
239000000377 silicon dioxide Substances 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
230000009870 specific binding Effects 0.000 description 2
238000010186 staining Methods 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
GRBBNZYMXKTQAI-UHFFFAOYSA-N 4-methyl-5-nitropyridin-2-amine Chemical compound CC1=CC(N)=NC=C1[N+]([O-])=O GRBBNZYMXKTQAI-UHFFFAOYSA-N 0.000 description 1
CDWGDLKZKCYUFO-UHFFFAOYSA-N 6-(trifluoromethyl)-1h-indole-2-carboxylic acid Chemical compound C1=C(C(F)(F)F)C=C2NC(C(=O)O)=CC2=C1 CDWGDLKZKCYUFO-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
235000006576 Althaea officinalis Nutrition 0.000 description 1
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
XZHWAGZSWOAEPI-UHFFFAOYSA-N C(C=CC1=CC(O)=C(O)C=C1)(=O)O.OC=1C=C(C=CC(=O)O)C=CC1O Chemical compound C(C=CC1=CC(O)=C(O)C=C1)(=O)O.OC=1C=C(C=CC(=O)O)C=CC1O XZHWAGZSWOAEPI-UHFFFAOYSA-N 0.000 description 1
OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
101100028791 Caenorhabditis elegans pbs-5 gene Proteins 0.000 description 1
102000009410 Chemokine receptor Human genes 0.000 description 1
108050000299 Chemokine receptor Proteins 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
101100377506 Drosophila melanogaster 14-3-3zeta gene Proteins 0.000 description 1
239000012630 HPLC buffer Substances 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
229920002292 Nylon 6 Polymers 0.000 description 1
229910003873 O—P—O Inorganic materials 0.000 description 1
241001494479 Pecora Species 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
108010026552 Proteome Proteins 0.000 description 1
238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 1
229910000831 Steel Inorganic materials 0.000 description 1
HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
239000011717 all-trans-retinol Substances 0.000 description 1
235000019169 all-trans-retinol Nutrition 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
150000001412 amines Chemical group 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
235000011114 ammonium hydroxide Nutrition 0.000 description 1
238000005571 anion exchange chromatography Methods 0.000 description 1
230000003172 anti-dna Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
230000012292 cell migration Effects 0.000 description 1
150000001793 charged compounds Chemical class 0.000 description 1
235000013985 cinnamic acid Nutrition 0.000 description 1
229930016911 cinnamic acid Natural products 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
108010057085 cytokine receptors Proteins 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
238000010511 deprotection reaction Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
239000000539 dimer Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
235000001785 ferulic acid Nutrition 0.000 description 1
KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
229940114124 ferulic acid Drugs 0.000 description 1
KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
239000003517 fume Substances 0.000 description 1
230000006870 function Effects 0.000 description 1
239000007792 gaseous phase Substances 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
108091008039 hormone receptors Proteins 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000011147 inorganic material Substances 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
239000011630 iodine Substances 0.000 description 1
238000010884 ion-beam technique Methods 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
239000002523 lectin Substances 0.000 description 1
238000011068 loading method Methods 0.000 description 1
125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000003550 marker Substances 0.000 description 1
238000001254 matrix assisted laser desorption--ionisation time-of-flight mass spectrum Methods 0.000 description 1
239000012528 membrane Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
CSHFHJNMIMPJST-HOTGVXAUSA-N methyl (2s)-2-[[(2s)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoate Chemical class NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)OC)CC1=CC=CC=C1 CSHFHJNMIMPJST-HOTGVXAUSA-N 0.000 description 1
WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
108091005601 modified peptides Proteins 0.000 description 1
239000003607 modifier Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
CMWYAOXYQATXSI-UHFFFAOYSA-N n,n-dimethylformamide;piperidine Chemical compound CN(C)C=O.C1CCNCC1 CMWYAOXYQATXSI-UHFFFAOYSA-N 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000011368 organic material Substances 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
WRMXOVHLRUVREB-UHFFFAOYSA-N phosphono phosphate;tributylazanium Chemical compound OP(O)(=O)OP([O-])([O-])=O.CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC WRMXOVHLRUVREB-UHFFFAOYSA-N 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920002981 polyvinylidene fluoride Polymers 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000008569 process Effects 0.000 description 1
125000006239 protecting group Chemical group 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000012488 sample solution Substances 0.000 description 1
238000001004 secondary ion mass spectrometry Methods 0.000 description 1
239000010703 silicon Substances 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
MKNJJMHQBYVHRS-UHFFFAOYSA-M sodium;1-[11-(2,5-dioxopyrrol-1-yl)undecanoyloxy]-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)CCCCCCCCCCN1C(=O)C=CC1=O MKNJJMHQBYVHRS-UHFFFAOYSA-M 0.000 description 1
241000894007 species Species 0.000 description 1
239000010959 steel Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
AVBGNFCMKJOFIN-UHFFFAOYSA-N triethylammonium acetate Chemical compound CC(O)=O.CCN(CC)CC AVBGNFCMKJOFIN-UHFFFAOYSA-N 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/004—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn
- H01J49/0045—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn characterised by the fragmentation or other specific reaction
- H01J49/0059—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn characterised by the fragmentation or other specific reaction by a photon beam, photo-dissociation
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Physics & Mathematics (AREA)
Bioinformatics & Cheminformatics (AREA)
Bioinformatics & Computational Biology (AREA)
Analytical Chemistry (AREA)
Hematology (AREA)
Spectroscopy & Molecular Physics (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Food Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Optics & Photonics (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Chemical Kinetics & Catalysis (AREA)
Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Peptides Or Proteins (AREA)
Electron Tubes For Measurement (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA2611266A 2005-06-07 2006-06-07 Utilisation de conjugues avec des lieurs clivables par photodissociation ou par fragmentation a des fins d'analyse par spectrometrie de masse des parties du tissu Expired - Fee Related CA2611266C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US68784805P	2005-06-07	2005-06-07
US60/687,848		2005-06-07
PCT/IB2006/002309 WO2007000669A2 (fr)	2005-06-07	2006-06-07	Utilisation de conjugues avec des lieurs clivables par photodissociation ou par fragmentation a des fins d'analyse par spectrometrie de masse des parties du tissu

Publications (2)

Publication Number	Publication Date
CA2611266A1 true CA2611266A1 (fr)	2007-01-04
CA2611266C CA2611266C (fr)	2015-11-24

Family

ID=37309311

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CA2611266A Expired - Fee Related CA2611266C (fr)	2005-06-07	2006-06-07	Utilisation de conjugues avec des lieurs clivables par photodissociation ou par fragmentation a des fins d'analyse par spectrometrie de masse des parties du tissu
CA002611297A Abandoned CA2611297A1 (fr)	2005-06-07	2006-06-07	Utilisation de matrices ioniques pour l'analyse par la spectrometrie de desorption-ionisation par impact laser assistee par matrice

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
CA002611297A Abandoned CA2611297A1 (fr)	2005-06-07	2006-06-07	Utilisation de matrices ioniques pour l'analyse par la spectrometrie de desorption-ionisation par impact laser assistee par matrice

Country Status (7)

Country	Link
US (2)	US8148676B2 (fr)
EP (6)	EP1891426B1 (fr)
JP (2)	JP2008542784A (fr)
AT (2)	ATE528644T1 (fr)
CA (2)	CA2611266C (fr)
ES (1)	ES2371203T3 (fr)
WO (2)	WO2007000669A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2515433C (fr) *	2003-02-24	2011-10-11	Simon Fraser University	Formation et irradiation de microtaches tres serrees
DE102007024857B4 (de) *	2007-05-29	2017-11-02	Bruker Daltonik Gmbh	Bildgebende Massenspektrometrie für kleine Moleküle in flächigen Proben
US20090286286A1 (en) *	2007-11-06	2009-11-19	Ambergen , Inc.	Methods for controlling amplification
JP5072682B2 (ja) *	2008-03-28	2012-11-14	富士フイルム株式会社	質量分析用デバイス、これを用いる質量分析装置および質量分析方法
JP5092861B2 (ja) *	2008-04-14	2012-12-05	株式会社島津製作所	混合液体マトリックスを用いたｍａｌｄｉ質量分析法
WO2010141763A1 (fr) *	2009-06-03	2010-12-09	Wayne State University	Spectrométrie de masse utilisant une technique d'ionisation par pulvérisation laser
EP3236264A3 (fr)	2009-10-13	2017-11-08	Nanostring Technologies, Inc	Détection de protéine par l'intermédiaire de nanorapporteurs
WO2011073740A1 (fr) *	2009-12-15	2011-06-23	Centre National De La Recherche Scientifique (Cnrs)	Matrices pour imagerie par spectrométrie de masse
US10787701B2 (en)	2010-04-05	2020-09-29	Prognosys Biosciences, Inc.	Spatially encoded biological assays
CA2794522C (fr)	2010-04-05	2019-11-26	Prognosys Biosciences, Inc.	Tests biologiques a codage spatial
US20190300945A1 (en)	2010-04-05	2019-10-03	Prognosys Biosciences, Inc.	Spatially Encoded Biological Assays
US9523680B2 (en)	2010-06-30	2016-12-20	Ambergen, Inc.	Global Proteomic screening of random bead arrays using mass spectrometry imaging
ES2676183T3 (es)	2010-07-02	2018-07-17	Ventana Medical Systems, Inc.	Detección de dianas usando marcas de masa y espectrometría de masas
GB201106254D0 (en)	2011-04-13	2011-05-25	Frisen Jonas	Method and product
FR2976076B1 (fr)	2011-05-31	2015-02-27	Imabiotech	Procede de detection et de quantification d'une molecule cible dans un tissu
EP2736533B1 (fr) *	2011-07-29	2018-07-04	Avelas Biosciences, Inc.	Molécules de délivrance sélective et procédés d'utilisation
EP2819702A4 (fr) *	2012-02-29	2015-05-20	Ambrx Inc	Nouveau promédicament contenant des compositions moléculaires et leurs utilisations
DK3511423T4 (da)	2012-10-17	2024-07-29	Spatial Transcriptomics Ab	Fremgangsmåder og produkt til optimering af lokaliseret eller rumlig detektion af genekspression i en vævsprøve
EP2767832A1 (fr)	2013-02-18	2014-08-20	Imabiotech	Conjugués chemolabiles ou photos pour la détection de molécules
US9645138B2 (en)	2013-02-25	2017-05-09	Imabiotech	Method to evaluate the tissue targeting of a molecule of interest
WO2014176435A2 (fr)	2013-04-25	2014-10-30	Bergo Vladislav B	Compositions de microréseaux et leurs procédés d'utilisation
US9868979B2 (en)	2013-06-25	2018-01-16	Prognosys Biosciences, Inc.	Spatially encoded biological assays using a microfluidic device
US10041949B2 (en) *	2013-09-13	2018-08-07	The Board Of Trustees Of The Leland Stanford Junior University	Multiplexed imaging of tissues using mass tags and secondary ion mass spectrometry
WO2015128272A2 (fr) *	2014-02-26	2015-09-03	Ventana Medical Systems, Inc.	Procédé photo-sélectif utilisable dans le domaine de l'analyse d'échantillons biologiques
DE102015003440A1 (de) *	2015-03-16	2016-09-22	Friedrich-Schiller-Universität Jena	Verfahren zur MALDI-MSI Analytik von Objekten, insbesondere biologischen Gewebeproben, und Target zur Analytik sowie dessen Herstellung
WO2016162309A1 (fr)	2015-04-10	2016-10-13	Spatial Transcriptomics Ab	Analyse de plusieurs acides nucléiques spatialement différenciés de spécimens biologiques
KR102545430B1 (ko)	2015-07-17	2023-06-19	나노스트링 테크놀로지스, 인크.	절편화된 조직의 사용자-한정된 영역에서의 복수의 단백질의 동시적인 정량화
WO2017015099A1 (fr) *	2015-07-17	2017-01-26	Nanostring Technologies, Inc.	Quantification simultanée de l'expression génique dans une région définie par l'utilisateur d'un tissu en coupe transversale
EP3882357B1 (fr)	2015-12-04	2022-08-10	10X Genomics, Inc.	Procédés et compositions pour l'analyse d'acide nucléique
WO2017151748A1 (fr) *	2016-03-01	2017-09-08	Trustees Of Boston University	Libération stimulée par la lumière de chargement à partir d'oligonucléotides
GR20160100143A (el) *	2016-04-11	2017-11-30	Αχιλλεας Αλεξανδρος Βαϊρης	Ελεγχος κατεργασιων συγκολλησης με τριβη
EP3336546B1 (fr) *	2016-12-13	2020-07-01	Miltenyi Biotec B.V. & Co. KG	Marquage de cellules réversible avec des conjugués ayant deux sites de liaison libérable
JPWO2018143357A1 (ja) *	2017-02-01	2019-11-21	国立大学法人浜松医科大学	標的物質と親和性の高い物質をスクリーニングする方法
US11391729B2 (en)	2017-09-07	2022-07-19	Adeptrix Corp.	Multiplexed bead arrays for proteomics
CN112154216B (zh)	2018-02-12	2024-12-27	布鲁克空间生物学公司	生物分子探针以及检测基因和蛋白表达的方法
CN109917058A (zh) *	2019-03-14	2019-06-21	南京农业大学	细胞内四种游离脱氧核苷酸的高效液相测定方法
JP7384358B2 (ja) *	2020-04-27	2023-11-21	株式会社島津製作所	有機化合物の構造解析方法
GB2626908B (en) *	2020-10-29	2025-07-16	Ambergen Inc	Methods of using photocleavable mass-tags comprising nucleic acid probes for multiplexed mass spectrometric imaging of tissues
CN113861074B (zh) *	2021-09-23	2025-01-24	中国检验检疫科学研究院	一种离子液体maldi基质的制备方法及应用
CN120202411A (zh) *	2022-11-18	2025-06-24	基因泰克公司	使用质量标签进行基于ia-lc-ms/ms的测定的信号放大和多重化
WO2024238393A1 (fr) *	2023-05-10	2024-11-21	Northwestern University	Imagerie et spectrométrie de masse de caractérisation de protéoformes

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4625014A (en) *	1984-07-10	1986-11-25	Dana-Farber Cancer Institute, Inc.	Cell-delivery agent
GB9315847D0 (en) *	1993-07-30	1993-09-15	Isis Innovation	Tag reagent and assay method
KR100473903B1 (ko)	1996-01-23	2005-09-30	퀴아진 지노믹스, 인코포레이티드	리간드쌍의결합을검출하는방법
US5808300A (en)	1996-05-10	1998-09-15	Board Of Regents, The University Of Texas System	Method and apparatus for imaging biological samples with MALDI MS
CA2274587A1 (fr) *	1996-12-10	1998-06-18	Genetrace Systems Inc.	Molecules d'etiquetage massique, non volatiles et liberables
GB9815166D0 (en) *	1998-07-13	1998-09-09	Brax Genomics Ltd	Compounds for mass spectrometry
US20030215421A1 (en)	1999-07-21	2003-11-20	Mcdonald John R.	Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
CA2371843A1 (fr)	1999-05-07	2000-11-16	Yale University	Analyse a etiquetage multiple
US6824981B2 (en)	2000-08-11	2004-11-30	Agilix Corporation	Ultra-sensitive detection systems using alterable peptide tags
AU2002240423B2 (en)	2001-02-14	2006-03-09	Picoliter Inc.	Acoustic sample introduction for analysis and/or processing
US7183116B2 (en) *	2001-05-14	2007-02-27	The Institute For Systems Biology	Methods for isolation and labeling of sample molecules
US6756586B2 (en) *	2001-10-15	2004-06-29	Vanderbilt University	Methods and apparatus for analyzing biological samples by mass spectrometry
DE10238069A1 (de) *	2002-08-19	2004-03-04	N.V. Nutricia	MALDI-Matrix
GB0228429D0 (en)	2002-12-05	2003-01-08	Novartis Ag	Organic compounds
WO2005067648A2 (fr)	2004-01-08	2005-07-28	Vanderbilt University	Profilage spatial multiplex d'expression genique
US7588906B2 (en)	2004-02-24	2009-09-15	Wisconsin Alumni Research Foundation	Hydrogels for biomolecule analysis and corresponding method to analyze biomolecules
US7618780B2 (en)	2004-05-20	2009-11-17	Trillion Genomics Limited	Use of mass labelled probes to detect target nucleic acids using mass spectrometry

2006
- 2006-06-07 AT AT06795327T patent/ATE528644T1/de not_active IP Right Cessation
- 2006-06-07 WO PCT/IB2006/002309 patent/WO2007000669A2/fr not_active Ceased
- 2006-06-07 AT AT06795326T patent/ATE520022T1/de not_active IP Right Cessation
- 2006-06-07 EP EP06795327A patent/EP1891426B1/fr not_active Not-in-force
- 2006-06-07 EP EP10167401.8A patent/EP2322921B1/fr not_active Not-in-force
- 2006-06-07 CA CA2611266A patent/CA2611266C/fr not_active Expired - Fee Related
- 2006-06-07 JP JP2008515318A patent/JP2008542784A/ja active Pending
- 2006-06-07 CA CA002611297A patent/CA2611297A1/fr not_active Abandoned
- 2006-06-07 US US11/916,558 patent/US8148676B2/en not_active Expired - Fee Related
- 2006-06-07 ES ES06795326T patent/ES2371203T3/es active Active
- 2006-06-07 EP EP10167400.0A patent/EP2322920B1/fr not_active Not-in-force
- 2006-06-07 EP EP06795326A patent/EP1889047B1/fr not_active Not-in-force
- 2006-06-07 EP EP10180422A patent/EP2287602A1/fr not_active Withdrawn
- 2006-06-07 EP EP10167398.6A patent/EP2325631B1/fr not_active Not-in-force
- 2006-06-07 WO PCT/IB2006/002311 patent/WO2007007192A1/fr not_active Ceased
- 2006-06-07 US US11/921,678 patent/US8221972B2/en not_active Expired - Fee Related
- 2006-06-07 JP JP2008515317A patent/JP5220593B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2007007192A1 (fr)	2007-01-18
WO2007000669A3 (fr)	2007-12-06
ATE528644T1 (de)	2011-10-15
ATE520022T1 (de)	2011-08-15
JP2008542783A (ja)	2008-11-27
EP1889047B1 (fr)	2011-08-10
EP2325631B1 (fr)	2015-01-28
US20080203289A1 (en)	2008-08-28
EP2322921A1 (fr)	2011-05-18
WO2007000669A2 (fr)	2007-01-04
EP1891426B1 (fr)	2011-10-12
EP2322921B1 (fr)	2014-08-06
EP2322920B1 (fr)	2014-12-10
JP2008542784A (ja)	2008-11-27
EP1889047A2 (fr)	2008-02-20
ES2371203T3 (es)	2011-12-28
CA2611266C (fr)	2015-11-24
JP5220593B2 (ja)	2013-06-26
US8221972B2 (en)	2012-07-17
EP2325631A1 (fr)	2011-05-25
US20110151451A1 (en)	2011-06-23
US8148676B2 (en)	2012-04-03
EP2287602A1 (fr)	2011-02-23
CA2611297A1 (fr)	2007-01-18
EP2322920A1 (fr)	2011-05-18
WO2007007192A8 (fr)	2008-04-17
EP1891426A1 (fr)	2008-02-27

Publication	Publication Date	Title
CA2611266C (fr)	2015-11-24	Utilisation de conjugues avec des lieurs clivables par photodissociation ou par fragmentation a des fins d'analyse par spectrometrie de masse des parties du tissu
DE19882657C2 (de)	2003-03-13	Massenspektrometrischer Nachweis von Polypeptiden
Cristoni et al.	2003	Development of new methodologies for the mass spectrometry study of bioorganic macromolecules
US7569392B2 (en)	2009-08-04	Multiplex spatial profiling of gene expression
Lane	2005	Mass spectrometry-based proteomics in the life sciences
EP2163900A1 (fr)	2010-03-17	Nouveau procédé d'imagerie par spectrométrie de masse et nouveaux dérivés de trityle associés à des marqueurs de masse
US20110172115A1 (en)	2011-07-14	Characterising planar samples by mass spectrometry
Steen et al.	2002	Analysis of protein–nucleic acid interactions by photochemical cross‐linking and mass spectrometry
JP2004340974A (ja)	2004-12-02	生体分子スクリーニングのための質量分析的方法
US20080242838A1 (en)	2008-10-02	Labeling reagent and methods of use
Köcher et al.	2003	Nanoelectrospray‐based detection and sequencing of substoichiometric amounts of phosphopeptides in complex mixtures
JP2009508135A (ja)	2009-02-26	質量標識体
Kweon et al.	2008	Metal oxide-based enrichment combined with gas-phase ion-electron reactions for improved mass spectrometric characterization of protein phosphorylation
EP3155436B1 (fr)	2023-08-30	Marqueurs de masse isobariques
Czeszak et al.	2002	Identification of substituted sites on MUC5AC mucin motif peptides after enzymatic O‐glycosylation combining β‐elimination and fixed‐charge derivatization
WO2005067648A2 (fr)	2005-07-28	Profilage spatial multiplex d'expression genique
Honda et al.	2008	Review of molecular modification techniques for improved detection of biomolecules by mass spectrometry
Cantel et al.	2012	An innovative strategy for sulfopeptides analysis using MALDI‐TOF MS reflectron positive ion mode
Wilson	2008	Development of photodissociation methods for biomolecule analysis in a quadrupole ion trap mass spectrometer
Gao	2008	Matrix-assisted laser desorption ionization time-of-flight studies of natural and synthetic peptides
AU4241702A (en)	2002-07-04	Mass spectrometric detection of polypeptides

Legal Events

Date	Code	Title	Description
2011-06-06	EEER	Examination request
2023-01-18	MKLA	Lapsed	Effective date: 20210607